X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
atopic dermatitis (36) 36
index medicus (29) 29
crisaborole (25) 25
dermatology (25) 25
humans (24) 24
dermatitis, atopic - drug therapy (18) 18
crisaborole topical ointment (17) 17
children (16) 16
crisaborole ointment (14) 14
dermatitis (13) 13
2-percent (12) 12
adult (12) 12
double-blind (12) 12
eczema (12) 12
open-label (12) 12
pharmacology & pharmacy (12) 12
quality of life (12) 12
safety (12) 12
calcineurin inhibitors (11) 11
child (11) 11
pruritus (10) 10
administration, cutaneous (9) 9
boron compounds - therapeutic use (9) 9
quality-of-life (9) 9
bridged bicyclo compounds, heterocyclic - therapeutic use (8) 8
female (8) 8
management (8) 8
adults (7) 7
dupilumab (7) 7
immunology (7) 7
male (7) 7
phosphodiesterase 4 inhibitors - therapeutic use (7) 7
skin barrier (7) 7
topical calcineurin inhibitors (7) 7
adolescents (6) 6
apremilast (6) 6
cyclic-amp-phosphodiesterase (6) 6
dermatologic agents - administration & dosage (6) 6
efficacy (6) 6
inflammation (6) 6
medicine & public health (6) 6
phase 2a (6) 6
phosphodiesterase-4 pde4 inhibitor (6) 6
psoriasis (6) 6
skin (6) 6
topical treatment (6) 6
administration, topical (5) 5
adolescent (5) 5
allergy (5) 5
care and treatment (5) 5
cytokines (5) 5
guidelines (5) 5
medical colleges (5) 5
middle aged (5) 5
moderate (5) 5
pde4 inhibitor (5) 5
pediatrics (5) 5
phosphodiesterase (5) 5
phosphodiesterase-4 inhibitor (5) 5
skin diseases (5) 5
topical corticosteroids (5) 5
topical ointment (5) 5
wet-wrap dressings (5) 5
young adult (5) 5
aged (4) 4
analysis (4) 4
animals (4) 4
boron compounds - adverse effects (4) 4
bridged bicyclo compounds, heterocyclic - adverse effects (4) 4
care (4) 4
clinical trials (4) 4
dermatologic agents - adverse effects (4) 4
dermatologic agents - therapeutic use (4) 4
disease (4) 4
drug design (4) 4
in-vitro (4) 4
internal medicine (4) 4
itch (4) 4
ointments (4) 4
patients (4) 4
pediatric-patients (4) 4
pharmacotherapy (4) 4
phosphodiesterase 4 (4) 4
pimecrolimus (4) 4
pimecrolimus cream 1-percent (4) 4
review (4) 4
surgery (4) 4
tacrolimus ointment (4) 4
tolerability (4) 4
united-states (4) 4
abridged index medicus (3) 3
administration, oral (3) 3
barrier function (3) 3
boron compounds - pharmacokinetics (3) 3
child, preschool (3) 3
dermatitis, atopic - diagnosis (3) 3
dermatitis, atopic - pathology (3) 3
dermatitis, atopic - therapy (3) 3
diagnosis (3) 3
disease severity (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of the Dermatology Nurses' Association, ISSN 1945-760X, 07/2017, Volume 9, Issue 4, pp. 205 - 207
Journal Article
Pediatric Dermatology, ISSN 0736-8046, 05/2019, Volume 36, Issue 3, pp. 404 - 405
Inflammatory linear verrucous epidermal nevus (ILVEN) is a chronic, a linear, or whorled array of inflammatory, following the lines of Blaschko. Treatment of... 
crisaborole | inflammatory linear verrucous epidermal nevus | PHOSPHODIESTERASE-4 INHIBITOR | PEDIATRICS | 2-PERCENT | TOPICAL OINTMENT | DERMATOLOGY | Mole (Dermatology) | Inflammation | Nevus
Journal Article
Acta Dermato-Venereologica, ISSN 0001-5555, 05/2018, Volume 98, Issue 5, pp. 484 - 489
Pruritus occurs in all patients with atopic dermatitis and requires quick relief to reduce disease exacerbation and improve quality of life. Crisaborole... 
Crisaborole | Pruritus | Phosphodiesterase 4 inhibitor | Atopic dermatitis | pruritus | MANAGEMENT | SAFETY | atopic dermatitis | crisaborole | 2-PERCENT | TOPICAL OINTMENT | PHASE 2A | CHILDREN | DERMATOLOGY | ITCH | QUALITY INDEX CDLQI | ADOLESCENTS | DISEASE | phosphodiesterase 4 inhibitor | atopicdermatitis | phosphodiesterase4inhibitor
Journal Article
Annals of Allergy, Asthma & Immunology, ISSN 1081-1206, 01/2018, Volume 120, Issue 1, pp. 10 - 22.e2
The implementation of treatment guidelines for atopic dermatitis is challenging, in part because of different guidance documents being used by different groups... 
MOLECULAR SIGNATURES | ECZEMA PREVALENCE | PRACTICE PARAMETER | TASK-FORCE | OBJECTIVE SCORAD | ALLERGY | CRISABOROLE TOPICAL OINTMENT | BAND UVB PHOTOTHERAPY | QUALITY-OF-LIFE | IMMUNOLOGY | SKIN BARRIER | MEDICINE SPECIFIC IMMUNOTHERAPY
Journal Article
Dermatology and Therapy, ISSN 2193-8210, 12/2018, Volume 8, Issue 4, pp. 605 - 619
The impact of crisaborole ointment, a nonsteroidal phosphodiesterase 4 inhibitor for the treatment of mild to moderate atopic dermatitis (AD), on quality of... 
Phosphodiesterase 4 | Plastic Surgery | Topical treatment | Dermatology | PDE4 | Quality of Life Research | Internal Medicine | Oral and Maxillofacial Surgery | Quality of life | Medicine & Public Health | Atopic dermatitis | Eczema | Crisaborole | ECZEMA | OPEN-LABEL | 2-PERCENT | TOPICAL OINTMENT | CHILDREN | DERMATOLOGY | INDEX CDLQI | IMPACT | Crisaborole Eczema | ADOLESCENTS | DISEASE | SEVERITY | Caregivers | Dermatitis
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 6/2018, Volume 19, Issue 3, pp. 319 - 332
Journal Article
American Journal of Clinical Dermatology, ISSN 1175-0561, 10/2016, Volume 17, Issue 5, pp. 425 - 443
Journal Article
Journal Article
Pediatric Drugs, ISSN 1174-5878, 8/2019, Volume 21, Issue 4, pp. 239 - 260
Journal Article